Objectives: There are more than 12 million long-term survivors of cancer in Europe. Yet, research on outcomes of cancer treatment has not reached its full potential due to operational, regulatory and methodological constrains. The current study aims to show the complementary roles between clinical research and population-based cancer registry in this research field. Methods: The authors used an empirical case study to show the level of agreement of variables between two databases of the same patients diagnosed with Hodgkin Lymphoma treated in the European Organisation for Research and Treatment of Cancer (EORTC) H1-H9 trials: one database is the clinical trial database from the EORTC and the other is the Netherlands Cancer Registry (IKNL). Results: The study showed a high level of agreement between the two datasets in most of the variables. However the vital status was more complete in the registry database, in particular for survivors diagnosed with cancer more than 10 years ago whereas treatment registration was more complete and in the EORTC clinical trial database. Conclusion: The current case study is based on one single disease area and one cancer registry, which needs further research to prove its feasibility in other settings. Nevertheless the authors have envisagedseveral actionable collaboration activities between clinical research organizations and population-based registries in long-term outcome studies in the future, including data linkage, joint methodology development, data quality cross-check and improvement program.
- Case study
- Clinical research organization
- Data linkage
- Hodgkin's lymphoma
- Population-based registries